<DOC>
	<DOCNO>NCT00290043</DOCNO>
	<brief_summary>To investigate type 1 diabetic patient glucodynamic response HMR1964 insulin RHI ( HOE31HPR100 ) inject subcutaneously standard meal</brief_summary>
	<brief_title>Glulisine Pre- Postmeal</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Insulin glulisine</keyword>
	<keyword>Diabetes mellitus Type 1</keyword>
	<keyword>Postprandial Period</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Glucodynamics</keyword>
</DOC>